Ads
-
Related paper
- FUNCTIONAL ACTIVITY OF P-GLYCOPROTEIN IN BLOOD-BRAIN BARRIER DURING EXPERIMENTAL PARKINSON'S SYNDROME
- FUNCTIONAL ACTIVITY OF P-GLYCOPROTEIN WITH UNDERLYING BRAIN ISCHEMIA
- FUNCTIONAL ACTIVITY OF P-GLYCOPROTEIN DURING EXPERIMENTAL MANIPULATIONS
- THE INFLUENCE OF EXPERIMENTAL SUBACUTE HYPOBARIC HYPOXIA ON P-GLYCOPROTEIN FUNCTIONAL ACTIVITY
- Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti Cancer Nanodrugs Delivery across the Blood Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation
- INFLUENCE OF VILDAGLIPTIN AND GLIQUIDONE COMBINATION ON P-GLYCOPROTEIN FUNCTIONAL ACTIVITY AND EXPRESSION ON THE BACKGROUND OF NORM AND IN EXPERIMENTAL ALLOXAN-INDUCED DIABETES MELLITUS TYPE 2
- PERMEABILITY OF BLOOD BRAIN BARRIER FOR CARDIOTROPIC SUBSTANCES UNDER HYPOTHERMIA AND HYPERTENSION
- Influence of the thyroxine on the functional activity of the р-glycoprotein in the experiment
- Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood-Brain Barrier (BBB) Translocation to Targeted Deliver Anti-Cancer Nano Drugs into the Human Brain to Treat Alzheimer's Disease under Synchrotron Radiation
- Hyperglycemia Damages the Endothelial Glycocalyx: Implications for The Blood Brain Barrier | Biomedgrid